BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28476018)

  • 21. Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer.
    Kim KP; Kim JE; Hong YS; Ahn SM; Chun SM; Hong SM; Jang SJ; Yu CS; Kim JC; Kim TW
    Cancer Res Treat; 2017 Jan; 49(1):161-167. PubMed ID: 27384156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Mutation Profiling of Colorectal Cancer Patients With Lung or Liver Metastasis by Targeted Next-Generation Sequencing.
    Hu CT; Wang JL; Hou T; Yan ZW; Zu LD; Fu GH; Shen WW
    Technol Cancer Res Treat; 2023; 22():15330338231185285. PubMed ID: 37394872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Analysis of Somatic Mutations in Colorectal Cancer With Peritoneal Metastasis.
    Lee JH; Ahn BK; Baik SS; Lee KH
    In Vivo; 2019; 33(2):447-452. PubMed ID: 30804124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors.
    Lin JK; Lin PC; Lin CH; Jiang JK; Yang SH; Liang WY; Chen WS; Chang SC
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S680-6. PubMed ID: 24841357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer.
    Reggiani Bonetti L; Barresi V; Bettelli S; Caprera C; Manfredini S; Maiorana A
    Hum Pathol; 2017 Apr; 62():91-98. PubMed ID: 28025078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
    Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
    Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of 13 driver genes of colorectal cancer-related pathways in Taiwanese patients.
    Chang YC; Chang JG; Liu TC; Lin CY; Yang SF; Ho CM; Chen WT; Chang YS
    World J Gastroenterol; 2016 Feb; 22(7):2314-25. PubMed ID: 26900293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
    Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples.
    Dallol A; Buhmeida A; Al-Ahwal MS; Al-Maghrabi J; Bajouh O; Al-Khayyat S; Alam R; Abusanad A; Turki R; Elaimi A; Alhadrami HA; Abuzenadah M; Banni H; Al-Qahtani MH; Abuzenadah AM
    J Transl Med; 2016 May; 14(1):118. PubMed ID: 27146902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
    Malapelle U; Mayo de-Las-Casas C; Rocco D; Garzon M; Pisapia P; Jordana-Ariza N; Russo M; Sgariglia R; De Luca C; Pepe F; Martinez-Bueno A; Morales-Espinosa D; González-Cao M; Karachaliou N; Viteri Ramirez S; Bellevicine C; Molina-Vila MA; Rosell R; Troncone G
    Br J Cancer; 2017 Mar; 116(6):802-810. PubMed ID: 28170370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic heterogeneity in primary colorectal carcinomas and their metastases: born bad or brought up a villain?
    Hühns M; Krohn S; Murua Escobar H; Prall F
    Hum Pathol; 2018 Apr; 74():54-63. PubMed ID: 29307628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of KRAS mutation in early onset colorectal adenocarcinoma: implications for pathogenesis.
    Watson R; Liu TC; Ruzinova MB
    Hum Pathol; 2016 Oct; 56():163-70. PubMed ID: 27346571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
    Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
    Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
    Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing.
    Liang Y; Jiang L; Zhong X; Hochwald SN; Wang Y; Huang L; Nie Q; Huang H; Xu JF
    Am J Med Sci; 2019 Nov; 358(5):340-349. PubMed ID: 31445671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer.
    Suzuki Y; Ng SB; Chua C; Leow WQ; Chng J; Liu SY; Ramnarayanan K; Gan A; Ho DL; Ten R; Su Y; Lezhava A; Lai JH; Koh D; Lim KH; Tan P; Rozen SG; Tan IB
    Mol Oncol; 2017 Feb; 11(2):124-139. PubMed ID: 28145097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copy number of the Adenomatous Polyposis Coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene.
    Zauber P; Marotta S; Sabbath-Solitare M
    BMC Cancer; 2016 Mar; 16():213. PubMed ID: 26970738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.